gimeracil,tegafur,nivolumab,capecitabine,oxaliplatin,oteracil
otsuka,bms,nordic group,ono pharma
['nivolumab', 'nivo', 'esophageal', 'gastroesophageal', 'attraction-5', 'gastric']
attraction-5: a phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage iii (pstage iii) gastric or gastroesophageal junction (g/gej) cancer. ( ) #asco23
Medicina Interna - Oncología, Clínica Astorga. Profesor titular @upbcolombia Medellín / Colombia #OncTwitter “De los expertos, líbrame Señor🙏🏻”